Cited by 972Cancer-related Molecular PathwaysDNA Repair MechanismsHeat shock proteins research

The DOI matches its Crossref record; 78 of the 84 references it cites were found in a registry or an index.

The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

Open access

Shieh, Sheau-Yann, Ahn, Jinwoo, Tamai, Katsuyuki, Taya, Yoichi, Prives, Carol·2000·Genes & Development

Open this paper in CoChat — free account Open PDF

Abstract

Upon DNA damage, the amino terminus of p53 is phosphorylated at a number of serine residues including S20, a site that is particularly important in regulating stability and function of the protein. Because no known kinase has been identified that can modify this site, HeLa nuclear extracts were fractionated and S20 phosphorylation was followed. We discovered that a S20 kinase activity copurifies with the human homolog of the Schizosaccharomyces pombe checkpoint kinase, Chk1 (hCHK1). We confirmed that recombinant hCHK1, but not a kinase-defective version of hCHK1, can phosphorylate p53 in vitro at S20. Additional inducible amino- and carboxy-terminal sites in p53 are also phosphorylated by hCHK1, indicating that this is an unusually versatile protein kinase. It is interesting that hCHK1 strongly prefers tetrameric to monomeric p53 in vitro, consistent with our observation that phosphorylation of amino-terminal sites in vivo requires that p53 be oligomeric. Regulation of the levels and activity of hCHK1 in transfected cells is directly correlated with the levels of p53; expression of either a kinase-defective hCHK1 or antisense hCHK1 leads to reduced levels of cotransfected p53, whereas overexpression of wild-type hCHK1 or the kinase domain of hCHK1 results in increased levels of expressed p53 protein. The human homolog of the second S. pombe checkpoint kinase, Cds1 (CHK2/hCds1), phosphorylates tetrameric p53 but not monomeric p53 in vitro at sites similar to those phosphorylated by hCHK1 kinase, suggesting that both checkpoint kinases can play roles in regulating p53 after DNA damage.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1101/gad.14.3.289

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Another p53 target gene, MDM2, encodes a p53-binding protein that negatively regulates the activity (Momand et al. 1992; Oliner et al. 1993) and the stability of p53 (Haupt et al. 1997; Kubbutat et al. 1997; Midgley and Lane 1997).”
Background
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Self-citation
Cell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,050
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Self-citation
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Self-citation
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,474

Show all 84 references

Research works printed but not linked: 1

Mayo, 1997, Mdm2 phosphorylation by DNA-dependent protein kinase prevents ineraction with p53., Cancer Res., 57, 5013

Sorted by citations

Items 801–900 of 964

The Role of p53 Molecule in Radiation and Hyperthermic Therapies
Yasumoto, J.-I., Takahashi, A., Ohnishi, K., & Ohnishi, T. (2003) · Eisei kagaku · doi:10.1248/jhs.49.273 · Cited by 3
Prédisposition héréditaire au cancer du sein (2)
Cohen‐Haguenauer, O. (2019) · médecine/sciences · doi:10.1051/medsci/2019072 · Cited by 3
DNA damage response manages cell cycle restriction of senile multipotent mesenchymal stromal cells
Lin, Y., Yu, F., Xu, Y., Wang, Y., Zuo, Y., Wang, C., & Ye, L. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05150-6 · Cited by 3
Erratum to: Controlling the response to DNA damage by the APC/C-Cdh1
de Boer, H. R., Llobet, S. G., & van Vugt, M. A. T. M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2279-x · Cited by 3
Functional Rescue of Mutant p53 as a Strategy to Combat Cancer
Selivanova, G., & Wiman, K. G. (2002) · Elsevier eBooks · doi:10.1016/b978-012476249-7/50021-7 · Cited by 3
Cell Cycle and Cancer
Mir, M. A., & Sofi, S. (2023) · Springer eBooks · doi:10.1007/978-981-19-8911-7_4 · Cited by 2
The Functionality of p53 in Thyroid Cancer
Ray, D., Matthew, T., & Gal, S. (2012) · InTech eBooks · doi:10.5772/25554 · Cited by 2
DNA Repair, Cancer and Cancer Therapy - The Current State of Art
İşbir, T., Demircan, B., Kıraç, D., Dalan, A. B., & Görmüş, U. (2011) · InTech eBooks · doi:10.5772/24147 · Cited by 2
TUMOR SUPPRESSOR PATHWAYS AND CELLULAR ORIGINS OF BREAST CANCER: NEW COMPLEXITIES AND NEW HOPES
Jerry, D. J., Griner, N. B., & Tao, L. (2010) · Nano LIFE · doi:10.1142/s179398441000002x · Cited by 2
Human herpesvirus-6B protein U19 contains a p53 BOX I homology motif for HDM2 binding and p53 stabilization
Kofod‐Olsen, E., Pettersson, S., Wallace, M., Abduljabar, A. B., Øster, B., Hupp, T. R., & Höllsberg, P. (2013) · Virology · doi:10.1016/j.virol.2013.10.002 · Cited by 2
p53 and the PWWP Domain Containing Effector Proteins in Chromatin Damage Repair
Wang, Y. (2012) · Cell & Developmental Biology · doi:10.4172/2168-9296.1000112 · Cited by 2
Hepatocellular carcinoma: Putative interactive mechanism between aflatoxins and hepatitis viral infections implicating oxidative stress during the onset and progression of cance
Mossanda, K. (2015) · Hypothesis · doi:10.5779/hypothesis.v13i1.260 · Cited by 2
Mutations of the CHEK2 gene in patients with cancer and their presence in the Latin American population
Guauque-Olarte, S., Rivera-Herrera, A.-L., & Cifuentes-C, L. (2016) · F1000Research · doi:10.12688/f1000research.9932.1 · Cited by 2
DNA Damage Response and the Balance Between Cell Survival and Cell Death
Kaina, B., Roos, W. P., & Christmann, M. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_7 · Cited by 2
HDM2 negatively affects the Chk2‐mediated phosphorylation of p53
Bjørling-Poulsen, M., Meek, D. W., & Issinger, O. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.081 · Cited by 2
L'activation de la protéine p53, un événement déterminant de la réponse cellulaire aux radiations ionisantes.
Drané, P., Álvarez, S. P., Meiller, A., & May, E. (2002) · Médecine Nucléaire · Cited by 2
CHARACTERIZATION OF THE DWNN DOMAIN AND RING FINGER-LIKE MOTIF WITHIN THE DCM OF THE Drosophila melanogaster SNAMA PROTEIN
Antunes, R. (2008) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg) · Cited by 2
Genexpressionsanalysen in humanen peripheren Blutlymphozyten nach Bestrahlung: Grundlagen für biodosimetrische Applikationen
Knops, K. (2013) · DuEPublico (University of Duisburg-Essen) · Cited by 2
Scale-down of CHO cell fed-batch cultures
Pan, X. (2018) · doi:10.18174/444363 · Cited by 2
Drugging p53 mutants: Recent advances using small-molecule modulation strategies
Lopes, E. A., Monteiro, T. G., & Santos, M. M. M. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119149 · Cited by 1
Points of Departure for BPDE-induced cellular senescence and cell death are characterized by altered DNA damage signaling and regulated by unrepaired DNA double-strand breaks
Schmidt, A., Schöneis, A., Sallbach, J., Pöschmann, A., Lippold, R., Rasenberger, B., Hofmann, T. G., Tomicic, M. T., & Christmann, M. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04426-8 · Cited by 1
Enhancing the efficacy of B7-H3-targeting antibody-drug conjugate DS-7300a in TP53-deficient tumors by inducing ferroptosis
Leo, J., Chen, F., Wei, S., Liang, X., Meng, C., Gu, Q., Albittar, Y., Fan, Z., Zhang, J., Gan, B., et al. (2026) · Oncogene · doi:10.1038/s41388-026-03921-7 · Cited by 1
Biomarkers to assess the efficiency of treatment with platinum-based drugs: what can metallomics add?
Araújo, T. D. O., Costa, L. T., Fernandes, J., Aucélio, R. Q., & Campos‐Vargas, R. (2014) · Metallomics · doi:10.1039/c4mt00192c · Cited by 1
DNA damage response genes and chromosome 11q21-q24 candidate tumor suppressor genes in breast cancer
Allinen, M. (2002) · Cited by 1
BRCA-1, BRCA-2, and Hereditary Breast Cancer
Betsy A. Bove, R. L. D., Jr. (2002) · CRC Press eBooks · doi:10.3109/9780203909249-22 · Cited by 1
Actualidad del melanoma dentro del espectro clínico del síndrome de Li Fraumeni
Tulcán, E. Y. B., & Pérez, A. V. (2022) · Piel · doi:10.1016/j.piel.2021.11.012 · Cited by 1
Genetic Syndromes and Radiotherapy in Breast Cancer
Green, C., Khan, A. J., & Haffty, B. G. (2015) · Medical radiology · doi:10.1007/174_2014_1046 · Cited by 1
Loss of Cdh1 Triggers Premature Senescence in Part via Activation of Both the RB/E2F1 and the CLASPIN/CHK1/P53 Tumor Suppressor Pathways
Shaik, S., Liu, P., Wang, Z. P., & Wei, W. (2013) · Springer eBooks · doi:10.1007/978-94-007-7726-2_20 · Cited by 1
Damage and Replication Stress Responses
Wang, H., Shen, P., & Zhu, W. (2011) · InTech eBooks · doi:10.5772/21986 · Cited by 1
In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2
Kim, S., Mohapatra, G., & Haber, D. A. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604644 · Cited by 2
Are Humanized Mouse Models Useful for Basic Research of Hepatocarcinogenesis through Chronic Hepatitis B Virus Infection?
Tsuge, M. (2021) · Viruses · doi:10.3390/v13101920 · Cited by 1
Par-4 in Cell Cycle Regulation
Zhang, Y., Mao, F., & Liu, X. (2022) · Springer eBooks · doi:10.1007/978-3-030-73572-2_2 · Cited by 1
Microarray Bioinformatics and Applications in Oncology
Peeters, J. K. (2008) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 1
Characterisation of the role of autophagy in DNA damage repair
Liu, E. Y. (2014) · Enlighten: Theses (The University of Glasgow) · Cited by 1
The p53 Pathway, Cancer and Aging
Braithwaite, A. W., & Edwards, S. J. (2003) · Springer eBooks · doi:10.1007/978-94-017-0669-8_8 · Cited by 1
The p53 Transcription Factor as Therapeutic Target in Cancer
Asker, C., Bykov, V. J. N., Méndez‐Vidal, C., Selivanova, G., Wilhelm, M., & Wiman, K. G. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18932-6_7 · Cited by 1
Chk1 and Chk2 as Checkpoint Targets
Zhang, H., Xiao, Z., & Sowin, T. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_16 · Cited by 1
Genetic Predisposition to Male and Female Breast Cancer
Syrjäkoski, K. (2004) · Tampere University Institutional Repository (Tampere University) · Cited by 1
Notch regulates the growth-promoting nitric oxide cGMP-dependent pathway in epithelial ovarian cancer and ovarian surface epithelium cells
El‐Sehemy, A. (2014) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3mt2g · Cited by 1
Multiple outcomes for PI3K/Akt/mTOR targeting in non-Hodgkin lymphoma
Müller, A. (2015) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/17284 · Cited by 1
The role of telomere damage in cardiomyocyte ageing
Anderson, R. K. (2016) · Cited by 1
Insertion of an intrinsically disordered domain in VelB supports selective heterodimer formation of fungal velvet domain regulatory proteins in Aspergillus nidulans
Thieme, S. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7389 · Cited by 2
Negative regulation of p53 by the poliovirus receptor PVR is a target of a human cytomegalovirus immune evasion moleculePreprint
Odell, A. F., Mannion, A. J., Jones, P. F., & Cook, G. P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.04.498680 · Cited by 1
Kinase Liabilities in Early Drug Discovery
Kirchner, S. (2024) · Wiley eBooks · doi:10.1002/9781394182862.ch6 · Cited by 1
Parallel networks that govern the transcriptional response to stress
Durham, S. A. (2022) · Scholars Archive - University at Albany (University at Albany, State University of New York) · doi:10.54014/9v8x-vd6d · Cited by 1
Regulation of the M-phase of cell cycle by CDK1, PP2A and CDC6
Dika, M. E. (2013) · doi:10.70675/55071395zf6b6z48d0zaae5z659fb6a2e630 · Cited by 1
ACTIONS OF PI3K-DELTA INHIBITOR, IDELALISIB, AND ITS COMBINATION WITH BENDAMUSTINE IN CHRONIC LYMPHOCYTIC LEUKEMIA
Modi, P. (2015) · Digital Commons-TMC (Texas Medical Center)
Targeting cell cycle checkpoints to specifically kill cancer
Burgess, A. (2004) · The University of Queensland · doi:10.14264/107006
DNA Damage and Oxidative Stress Induced-p53 Activity In Astrocytes causes Growth Arrest
Humphrey, S. A. (2012) · Scholarship@Western (Western University)
Dissecting the non-canonical functions of p53 through novel target identification and p53 acetylation
Wang, S.-J. (2014) · doi:10.7916/d85b00m3
REGULATION OF DNA DAMAGE PROCESSING BY COVALENT MODIFICATION OF THYMINE DNA GLYCOSYLASE (Spine title: Regulation of DNA damage processing by thymine DNA glycosylase) (Thesis format: Integrated-Article)
Mohan, R. D. (2010) · Scholarship@Western (Western University)
Tumor suppressor p53 and transcriptional changes in cellular stress responses to UV radiation
Latonen, L. (2003) · Työväentutkimus Vuosikirja
Differences in the regulation of Thrombospondin-1 expression between epithelial cells and fibroblasts
Rodriguez, R. K. (2007) · DSpace@MIT (Massachusetts Institute of Technology)
CHK2 is Negatively Regulated by Protein Phosphatase 2A
Freeman, A. K. (2010) · Digital Commons - University of South Florida (University of South Florida)
THE ROLE OF P53 IN OXIDATIVE STRESS AND POLYGLUTAMINE NEUROTOXICITY
Dunn, J. C. (2003) · UKnowledge (University of Kentucky)
Investigation into the stability of WEE1 kinase in plants
Cook, G. S. (2012) · ORCA Online Research @Cardiff (Cardiff University)
Genetic determinants of postmenopausal breast and endometrial cancer
Einarsdóttir, K. (2007) · Figshare
Cell Cycle Control
Matthews, D. J., & Gerritsen, M. E. (2010) · Wiley eBooks · doi:10.1002/9780470555293.ch6
E2F1 induction following DNA damage and oncogene activation
Helgason, G. V. (2007) · Enlighten: Theses (The University of Glasgow)
ATM Deficiency -- A Multifaceted Defect in Lymphocyte Development
Helmink, B. A. (2012) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7k07291
c-Abl independent p73 stabilization during Gemcitabine or 4’-Thio-β-D-arabinofuranosyl cytosine (T-araC) induced apoptosis in wild-type and p53-null colorectal cancer cells
Thottassery, J. V., Westbrook, L., Someya, H., & Parker, W. B. (2006) · Cancer Research
Biochemical and functional analysis of TBP-containing complexes
Spedale, G. (2011) · Utrecht University Repository (Utrecht University)
DNA Damage, Checkpoint Responses, and Cell Cycle Control in Aging Stem Cells
Sperka, T., Nalapareddy, K., & Rudolph, K. L. (2010) · Else Kröner-Fresenius Symposia · doi:10.1159/000312653
DNA Damage Checkpoint Signaling Pathways in Human Cancer
Abraham, R. T., & Halazonetis, T. D. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1216-8_3
Rb Inactivation Leads to E2F1-mediated DNA Double Strand Break Accumulation: A Dissertation
Pickering, M. (2006) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/h6jf-nf65
Funktionelle Interaktionen zwischen Wildtyp-p53, Rad51 und Poly-ADP-Phosphoribosyl-Transferase bei der Kontrolle von DNA-Rekombinationsprozessen
Süße, S. (2004)
To reactivate or not to reactivate : Control of KSHV lytic replication is essential for apoptosis in response to p53 restoration
Sarek, G. (2010) · Työväentutkimus Vuosikirja
Apoptotic signaling in lung carcinoma cells : With focus on mechanisms of radioresistance
Ekedahl, J. (2003) · Figshare
CHEK2 in Breast and Colorectal Cancer
Kilpivaara, O. (2007) · Työväentutkimus Vuosikirja
Involvement of p53 in the S-phase Checkpoint during Nucleotide Deficiencies
Heyer, C. L. (2011) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/4zf5-2439
CHEK2 1100delC and polygenic susceptibility to breast cancer and colorectal cancer
Wasielewski, M. (2009) · RePub (Erasmus University Rotterdam)
Identifikation von Stressresistenzgenen in hämatologischen Neoplasien in Mus musculus (Linnaeus, 1758)
Engelmann, A. (2006)
A Functional Analysis of the RNA Polymerase II Large Subunit C-Terminal Domain
Chapman, R. D. (2003) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.1104
Post-translational Modifications of the p53 Transcription Factor
Brooks, C. L., & Gu, W. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-40049-5_15
Spy1 Regulation of the DNA Damage Response; Checkpoint Activation and Cellular Senescence
Jalili, E. (2013)
Función del gen Snai3 (Smuc) en la transición epitelio mesenquimal y en cáncer
Gutsche, K. (2009) · Gredos (University of Salamanca) · doi:10.14201/gredos.76287
Role of checkpoint kinase 1 in malignant melanoma
Smith, J. (2013) · Enlighten: Theses (The University of Glasgow)
Quantitative Analysis for p53 Tetramerization Domain Mutants Reveals a Low Threshold for Tumor Suppressor Inactivation
Kamada, R. (2012) · Springer theses · doi:10.1007/978-4-431-54135-6_2
DNA-Schadensantwort und ihre pharmakologische Beeinflussung
Kaina, B., & Christmann, M. (2011) · Der Onkologe · doi:10.1007/s00761-011-2028-6
Centriolar and ciliary responses to DNA damage
Conroy, P. C. (2012) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/16788
Keeping a CHEK on breast cancer
Weitzman, J. B. (2002) · Genome biology · doi:10.1186/gb-spotlight-20020424-02
DNA damage‐inducible phosphorylation of p53 at Ser20 is required for p53 stabilization
Yang, D., Rhee, B. K., Yim, T. H., Lee, H. J., & Kim, J. (2002) · Korean Journal of Biological Sciences · doi:10.1080/12265071.2002.9647661
Novel Role of CHK2 in the Intrinsic and Extrinsic Apoptosis Pathway
Agarwal, A. (2014) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7ng4nnv
p53 and DNA damage checkpoint responses in the human prostate
af Hällström, T. (2007)
Inhibition of Nucleolar Proteins in Caenorhabditis elegans Confers Enhanced Resistance to Salmonella enterica Through a p53/cep-1-Dependent Mechanism
Fuhrman, L. E. (2009)
Pharmacological targeting of mutant p53 family members
Rökaeus, N. (2011) · Figshare
The Role and Regulation of the Phosphatase PPM1D in Chemoresistant Gynecological Cancers
Ali, A. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-3512
Regulation of G2/M Transition in Mammalian Cells by Oxidative Stress
Li, G., Nair, S. S., Lees, S. J., & Booth, F. W. (2005) · ASME International Mechanical Engineering Congress and Exposition (IMECE) · doi:10.1115/imece2005-82349
Studies on early cellular responses during Epstein-Barr virus infection
Chen, X. (2015) · Figshare
Synergistic Effects of BubR1 and p53 Deficiency in Tumor Formation
Wiles, W. G. (2006)
DOCTEUR DE L'UNIVERSITÉ DE GRENOBLE
Vu, H. L. (2011)
Serine 379 Signaling through Autophosphorylation of Regulation of Chk2 Ubiquitination and
Piwnica-Worms, H. M., Lovly, C. M., Yan, L., & Ryan, C. E. (2014)
THE ROLE AND REGULATION of MITOCHONDRIAL DYNAMICS IN CISPLATIN RESISTANCE IN HUMAN GYNECOLOGIC CANCER CELLS
Kong, B. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-6589
Characterisation of the human DNA damage response and replication protein Topoisomerase IIβ Binding Protein 1 (TopBP1)
Reini, K. (2006)
Aberrations of DNA Damage in Checkpoints in Cancer
Laiho, M. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-200-7_5
Regulation of apoptosis by mar binding protein smar1
Sinha, S. (2009) · INFLIBNET
Combining gemcitabine with checkpoint kinase inhibitors to sensitize pancreatic tumors
Saini, P. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5028
Mechanisms of p53-mediated Intrinsic and Extrinsic Tumor Suppression
Selivanova, G., Höglund, P., Piaggio, G., Elena, R., Pereira, T., Wright, A. R., Wadelius, C., & Universitit, U. (2014)
ATM-Independent Manner Mutated (ATM)-Dependent and an Apoptosis in both an Ataxia Telangiectasia Chk2 Is a Tumor Suppressor That Regulates
Jeggo, P. A., Elledge, S. J., Mak, T. W., Bristow, R. G., Suda, T., Lowe, S. W., Sarkissian, T., Wong, J. A., Sakai, T., Elia, A., et al. (2014)
Characterization of an autoimmune gene expression signature.
Maas, K. H. (2006)

Authors: Shieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C.
Affiliations: Seisen University (JP)
ORCID: Shieh, Sheau-Yann
Tamai, Katsuyuki
Prives, Carol
Venue: Genes & Development
Publisher: Cold Spring Harbor Laboratory
Published: 2000-02-01
Volume: 14
Issue: 3
Pages: 289-300
ISSN: 0890-9369 (ISSN-L)
1549-5477
DOI: 10.1101/gad.14.3.289
PMC: PMC316358
OpenAlex: W2120921507
Cited by: 972
References: 84
Citations by year: 2026: 11 · 2025: 4 · 2024: 15 · 2023: 22 · 2022: 21 · 2021: 21 · 2020: 28 · 2019: 26 · 2018: 22 · 2017: 19 · 2016: 22 · 2015: 24 · 2014: 39 · 2013: 38 · 2012: 42
Type: posted content
Language: en
Open access: bronze
doi.org
Locations: Genes & Development (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Princess Takamatsu Cancer Research Fund
National Institutes of Health (CA58316)
National Cancer Institute (R37CA058316, R01CA058316, CA 58316)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Keywords: p53 phosphorylation, Chk1, Chk2, checkpoint kinase, DNA damage response, p53 oligomerization, p53 stabilization, Schizosaccharomyces pombe, kinase activity
MeSH terms: Checkpoint Kinase 1, DNA Damage, HeLa Cells, Humans, Phosphorylation, Protein Kinases, Recombinant Proteins, Blotting, Western, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Protein Structure, Tertiary, Schizosaccharomyces pombe Proteins, Checkpoint Kinase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks